KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Restructuring Costs: 2022-2023

Historic Restructuring Costs for Neogenomics (NEO) over the last 2 years, with Dec 2023 value amounting to $11.1 million.

  • Neogenomics' Restructuring Costs fell 48.80% to $2.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $8.8 million, marking a year-over-year change of. This contributed to the annual value of $11.1 million for FY2023, which is 145.53% up from last year.
  • As of FY2023, Neogenomics' Restructuring Costs stood at $11.1 million, which was up 145.53% from $4.5 million recorded in FY2022.
  • Neogenomics' Restructuring Costs' 5-year high stood at $11.1 million during FY2023, with a 5-year trough of $4.5 million in FY2022.
  • Its 2-year average for Restructuring Costs is $7.8 million, with a median of $7.8 million in 2022.
  • Data for Neogenomics' Restructuring Costs shows a peak YoY spiked of 145.53% (in 2023) over the last 5 years.
  • Neogenomics' Restructuring Costs (Yearly) stood at $4.5 million in 2022, then skyrocketed by 145.53% to $11.1 million in 2023.